Abstract
Evidence on the benefit of screening in women younger than 50 years is controversial. It is interesting to know if these women are being benefited through the improvement of morbimortality indicators in a population that extensively practices the opportunistic screening in this age group. To this end, a population-based study will be carried out to evaluate the age and the morbimortality …